4.5 Article

SARS-CoV-2 Omicron variant emerged under immune selection

Journal

NATURE MICROBIOLOGY
Volume 7, Issue 11, Pages 1756-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41564-022-01246-1

Keywords

-

Categories

Funding

  1. Singapore National Research Foundation [NRF2016NRF-NSFC002-013, NRF2018NRF-NSFC003SB-002]
  2. National Medical Research Council [STPRG-FY19-001, COVID19RF-003, COVID19RF-060, MOH-000535/MOH-OFYIRG19nov-0002, OFLCG19May-0034]
  3. Faculty of Medicine, Chulalongkorn University [RA(PO)002/64]
  4. King Chulalongkorn Memorial Hospital Fund for research [HA-64-3300-21-024]
  5. Biobank, Faculty of Medicine, Chulalongkorn University
  6. Bill and Melinda Gates award [INV-018944]
  7. National Institutes of Health [R01 AI138546]
  8. South African Medical Research Council [6084-CO-AP-2020]

Ask authors/readers for more resources

The study found that the Omicron variant of SARS-CoV-2 can escape neutralizing antibodies against the ancestral virus. Bat and pangolin sarbecoviruses showed less neutralization escape compared to the Omicron variant. This suggests that SARS-CoV-2 variants are evolving differently from animal sarbecoviruses under immune selection pressure.
The SARS-CoV-2 Omicron variant (B.1.1.529 lineage) escapes antibodies that neutralize the ancestral virus. We tested human serum panels from participants with differing infection and vaccination status using a multiplex surrogate virus neutralization assay targeting 20 sarbecoviruses. We found that bat and pangolin sarbecoviruses showed significantly less neutralization escape than the Omicron variant. We propose that SARS-CoV-2 variants have emerged under immune selection pressure and are evolving differently from animal sarbecoviruses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available